Subject: RXMD CEO Honored with Another Prestigious Speaking Engagement

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD CEO Honored with Another Prestigious Speaking Engagement
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.06

Change (%): + 0.00 (0.00)

Volume: 84,264
RXMD Chart

Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida

MIAMI, Nov. 01, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the 5th Annual Florida Telehealth Summit, an event aimed at connecting key telehealth champions to learn about the applications, research, and legal aspects of telehealth in Florida. The event takes place from Nov. 7-9 in St. Pete Beach, Florida.

S. Parikh Mars, CEO of Progressive Care Inc., will be leading a breakout session titled The Digital Pharmacy: Where Personalization Meets Tech from 3:15 p.m. - 4:15 p.m. ET on Thursday, Nov. 8, 2018. Mars will discuss the key components needed when implementing a successful tele-pharmacy model, best practices for balancing personalization with automation in a rapidly expanding marketplace, and how the tele-pharmacy model can help decrease non-adherence and increase profitability. Mars will also demonstrate the functions of the company’s propriety tele-pharmacy platform, Tele-PharmCo.

“I am honored to speak at such a relevant industry summit,” Mars said. “The conference’s focus on telehealth and the implementation of best technology practices within healthcare very much aligns with Progressive Care’s approach to offering innovative healthcare solutions for patients and physicians. I look forward to discussing and demonstrating our own proprietary tele-pharmacy model, Tele-PharmCo, and engaging with other industry leaders in telehealth.”

Tele-PharmCo will facilitate two-way video conferencing between patients, healthcare professionals, and PharmCo’s team of pharmacists and pharmacy technicians through a secure video interface. The new multi-platform technology software will allow patients and their care providers to connect and interact with licensed pharmacists and pharmacy technicians in real time and speak directly about medications, prescription refills, adverse reactions, and other concerns.

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks